# The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

> **NCT05602649** · PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 80 (estimated)

## Conditions studied

- Cannabis Use

## Interventions

- **DRUG:** Cannabis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05602649
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05602649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05602649, "The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05602649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*